Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

Bespak, Orbia Fluor & Energy Materials collaborate to accelerate transition to climate-friendly inhalers: Holmes Chapel, UK Thursday, November 7, 2024, 18:00 Hrs [IST] Bespak, a s ...